Bright Minds Biosciences Inc. Share Price
NASDAQ: DRUGBright Minds Biosciences Inc. Stock Performance
Bright Minds Biosciences Inc. Share Price Today
As of 31 October 2026, Bright Minds Biosciences Inc.'s share price is $55.19. The stock opened at $56.72, compared to its previous close of $57.12. During today's trading session, Bright Minds Biosciences Inc.'s share price traded between $54.96 and $56.72, with an average price of $55.84. Over the past 52 weeks, the stock has recorded a high of $120.06 and a low of $47.87. In terms of performance, Bright Minds Biosciences Inc.'s share price has declined by 37.10% over the last six months and is up 1.43% on a year-on-year basis.
Bright Minds Biosciences Inc. Share Price Chart
Bright Minds Biosciences Inc. Annual Profit & Loss
All figures in USD
About Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Bright Minds Biosciences Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $51.44 | $55.10 | +11.68% |
Sep 2026 | $71.06 | $49.34 | -34.00% |
Aug 2026 | $72.31 | $74.76 | +1.73% |
Jul 2026 | $71.66 | $73.49 | +4.61% |
Jun 2026 | $87.34 | $70.25 | -20.17% |
May 2026 | $88.50 | $88.00 | +0.30% |
Apr 2026 | $73.25 | $87.74 | +20.61% |
Mar 2026 | $80.00 | $72.75 | -12.84% |
Feb 2026 | $80.95 | $83.47 | +6.65% |
Jan 2026 | $79.44 | $78.26 | -0.29% |
Dec 2025 | $70.00 | $78.49 | +12.24% |
Nov 2025 | $51.44 | $69.93 | +28.52% |